Gene: BTBD19
Official Full Name: BTB domain containing 19provided by HGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO22453 | BTBD19 Knockout cell line (HeLa) | Human | BTBD19 | 1:3~1:6 | Negative | Online Inquiry |
KO22454 | BTBD19 Knockout cell line (HCT 116) | Human | BTBD19 | 1:2~1:4 | Negative | Online Inquiry |
KO22455 | BTBD19 Knockout cell line (A549) | Human | BTBD19 | 1:3~1:4 | Negative | Online Inquiry |
BTBD19 Gene Knockout Cell Lines are specifically engineered cellular models in which the BTBD19 gene has been inactivated, allowing researchers to elucidate the role of this gene in various biological processes. These cell lines facilitate the investigation of gene function, interactions, and the phenotypic consequences of BTBD19 deficiency, providing a valuable tool for both basic and translational research.
The primary mechanism of action involves the use of CRISPR-Cas9 technology, which precisely targets the BTBD19 locus for gene editing. This knockout results in an inability to express the BTBD19 protein, which has been implicated in several cellular processes, including immune response regulation and cellular signaling. By employing these knockout cell lines, researchers can explore the resulting changes in cellular dynamics, leading to insights into disease mechanisms or potential therapeutic targets.
The scientific importance of BTBD19 Gene Knockout Cell Lines extends into various applications, ranging from basic research in genetics and molecular biology to more applied fields such as pharmacology and disease modeling. Clinicians and researchers can utilize these models to better understand conditions influenced by BTBD19, potentially facilitating the development of targeted therapies or diagnostics.
What sets our BTBD19 Gene Knockout Cell Lines apart from alternatives is their high fidelity and the robustness of the knockout achieved through our precisely optimized CRISPR techniques. Additionally, each line is extensively validated for quality, ensuring reproducible results, which is crucial for rigorous scientific inquiry.
These cell lines present exceptional value not only for their experimental versatility but also for their potential to unlock new understanding in gene-related diseases. Researchers and clinicians alike will find these tools invaluable as they strive to advance the frontiers of biomedical science.
Our company has extensive expertise in the design and development of genetically modified cell lines, backed by a commitment to innovation and quality, ensuring that our products empower scientists to achieve breakthroughs in their research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.